Dow Up0.11% Nasdaq Up0.50%

Zoetis Inc. (ZTS)

35.44 Up 0.11(0.31%) Aug 29, 4:02PM EDT
|After Hours : 35.44 Up 0.00 (0.01%) Aug 29, 4:44PM EDT
ProfileGet Profile for:
Zoetis Inc.
100 Campus Drive
Florham Park, NJ 07932
United States - Map
Phone: 973-822-7000

Index Membership:N/A
Industry:Drugs - Generic
Full Time Employees:9,800

Business Summary 

Zoetis Inc. is engaged in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals worldwide. It operates through four segments: United States, Europe/Africa/Middle East, Canada/Latin America, and Asia/Pacific. The company offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines that are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. It also provides medicated feed additives that offer medicines to livestock; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy, and dermatology products, as well as reproductive products. The company markets its products to veterinarians and livestock producers through its sales representatives, and technical and veterinary operations specialists. Zoetis Inc. was founded in 1952 and is headquartered in Florham Park, New Jersey.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Zoetis Inc.

Corporate Governance 
Zoetis Inc.’s ISS Governance QuickScore as of Aug 1, 2014 is 6. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 8; Compensation: 2.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. Juan Ram Alaix , 63
Chief Exec. Officer and Director
Ms. Kristin C. Peck , 42
Group Pres and Exec. VP
Ms. Catherine A. Knupp , 53
Pres of R&D and Exec. VP
Mr. Clinton A. Lewis Jr., 47
Exec. VP and Pres of U.S. Operations
Mr. Glenn David ,
Acting Chief Financial Officer and Sr. VP
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders